Literature DB >> 19752292

Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells.

John J Gildea1, Jonathan A Israel, Andrew K Johnson, Jin Zhang, Pedro A Jose, Robin A Felder.   

Abstract

In moderate sodium-replete states, dopamine 1-like receptors (D1R/D5R) are responsible for regulating >50% of renal sodium excretion. This is partly mediated by internalization and inactivation of NaKATPase, when associated with adapter protein 2. We used dopaminergic stimulation via fenoldopam (D1-like receptor agonist) to study the interaction among D1-like receptors, caveolin-1 (CAV1), and the G protein-coupled receptor kinase type 4 in cultured human renal proximal tubule cells (RPTCs). We compared 2 groups of RPTCs, 1 of cell lines that were isolated from normal subjects (nRPTCs) and a second group of cell lines that have D1-like receptors that are uncoupled (uncoupled RPTCs) from adenylyl cyclase second messengers. In nRPTCs, fenoldopam increased the plasma membrane expression of D1R (10.0-fold) and CAV1 (1.3-fold) and markedly decreased G protein-coupled receptor kinase type 4 by 94+/-8%; no effects were seen in uncoupled RPTCs. Fenoldopam also increased the association of adapter protein 2 and NaKATPase by 53+/-9% in nRPTCs but not in uncoupled RPTCs. When CAV1 expression was reduced by 86.0+/-8.5% using small interfering RNA, restimulation of the D1-like receptors with fenoldopam in nRPTCs resulted in only a 7+/-9% increase in association between adapter protein 2 and NaKATPase. Basal CAV1 expression and association with G protein-coupled receptor kinase type 4 was decreased in uncoupled RPTCs (58+/-5% decrease in association) relative to nRPTCs. We conclude that the scaffolding protein CAV1 is necessary for the association of D1-like receptors with G protein-coupled receptor kinase type 4 and the adapter protein 2-associated reduction in plasma membrane NaKATPase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752292      PMCID: PMC2897144          DOI: 10.1161/HYPERTENSIONAHA.109.134338

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  54 in total

1.  Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.

Authors:  D P O'Connell; N V Ragsdale; D G Boyd; R A Felder; R M Carey
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

2.  Intrarenal dopamine acts at the dopamine-1 receptor to control renal function.

Authors:  H M Siragy; R A Felder; N E Howell; R L Chevalier; M J Peach; R M Carey
Journal:  J Hypertens Suppl       Date:  1988-12

3.  Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.

Authors:  S S Hedge; A Ricci; F Amenta; M F Lokhandwala
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

4.  Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension.

Authors:  J Xu; X X Li; F E Albrecht; U Hopfer; R M Carey; P A Jose
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

Review 5.  D1 dopamine receptor signalling defect in spontaneous hypertension.

Authors:  R A Felder; G M Eisner; P A Jose
Journal:  Acta Physiol Scand       Date:  2000-01

6.  Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4.

Authors:  Hidetsuna Watanabe; Jing Xu; Chikh Bengra; Pedro A Jose; Robin A Felder
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

7.  Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.

Authors:  M Haney; A S Ward; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

8.  Localization of intracellular compartments that exchange Na,K-ATPase molecules with the plasma membrane in a hormone-dependent manner.

Authors:  R Efendiev; K Das-Panja; A R Cinelli; A M Bertorello; C H Pedemonte
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

9.  beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics.

Authors:  Jonathan D Violin; Lisa M DiPilato; Necmettin Yildirim; Timothy C Elston; Jin Zhang; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2007-11-28       Impact factor: 5.157

10.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.

Authors:  M P Lisanti; P E Scherer; J Vidugiriene; Z Tang; A Hermanowski-Vosatka; Y H Tu; R F Cook; M Sargiacomo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

View more
  23 in total

1.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

Review 2.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Lipid rafts are required for effective renal D1 dopamine receptor function.

Authors:  Andrew C Tiu; Jian Yang; Laureano D Asico; Prasad Konkalmatt; Xiaoxu Zheng; Santiago Cuevas; Xiaoyan Wang; Hewang Lee; Momina Mazhar; Robin A Felder; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-07       Impact factor: 5.191

4.  The Dopamine D1 Receptor and Angiotensin II Type-2 Receptor are Required for Inhibition of Sodium Transport Through a Protein Phosphatase 2A Pathway.

Authors:  John J Gildea; Peng Xu; Brandon A Kemp; Robert M Carey; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

5.  Dopamine D₁-like receptors regulate the α₁A-adrenergic receptor in human renal proximal tubule cells and D₁-like dopamine receptor knockout mice.

Authors:  Riley Charles Ennis; Laureano D Asico; Ines Armando; Jian Yang; Jun B Feranil; Julie A Jurgens; Crisanto S Escano; Peiying Yu; Xiaoyan Wang; David R Sibley; Pedro A Jose; Van Anthony M Villar
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-22

6.  Differential dopamine receptor subtype regulation of adenylyl cyclases in lipid rafts in human embryonic kidney and renal proximal tubule cells.

Authors:  Peiying Yu; Min Sun; Van Anthony M Villar; Yanrong Zhang; Edward J Weinman; Robin A Felder; Pedro A Jose
Journal:  Cell Signal       Date:  2014-07-15       Impact factor: 4.315

Review 7.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

8.  Dopamine regulation of Na+-K+-ATPase requires the PDZ-2 domain of sodium hydrogen regulatory factor-1 (NHERF-1) in opossum kidney cells.

Authors:  Sarah Salyer; Nina Lesousky; Edward J Weinman; Barbara J Clark; Eleanor D Lederer; Syed J Khundmiri
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-15       Impact factor: 4.249

9.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

10.  D1-like dopamine receptors downregulate Na+-K+-ATPase activity and increase cAMP production in the posterior gills of the blue crab Callinectes sapidus.

Authors:  Francis B Arnaldo; Van Anthony M Villar; Prasad R Konkalmatt; Shaun A Owens; Laureano D Asico; John E Jones; Jian Yang; Donald L Lovett; Ines Armando; Pedro A Jose; Gisela P Concepcion
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-30       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.